U.S. Stem Cell, Inc. (USRM)

U.S. Stem Cell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	0	3	3	5	1	6
Market Cap Growth	-	2.70%	-47.21%	275.94%	-76.19%	-34.72%
Enterprise Value	-	12	11	13	8	10
PE Ratio	-	-0.86	-0.64	-1.55	-0.28	-2.71
PS Ratio	3.21	34.61	13.77	18.90	0.45	0.87
PB Ratio	0	-0.19	-0.22	-0.45	-0.15	-0.85
P/FCF Ratio	-	-9.31	-2.61	-10.94	-1.01	9.71
P/OCF Ratio	-	-9.31	-2.61	-10.94	-1.15	9.71
EV/Sales Ratio	-	143.59	53.51	45.85	2.47	1.42
EV/EBITDA Ratio	-	-6.85	-4.70	-5.24	-2.56	-14.84
EV/EBIT Ratio	-	-4.90	-3.29	-4.42	-2.37	-11.23
EV/FCF Ratio	-	-38.65	-10.15	-26.53	-5.50	15.84
Debt / Equity Ratio	0	-0.61	-0.63	-0.65	-0.65	-0.73
Debt / EBITDA Ratio	-	-5.20	-3.50	-3.09	-2.09	-7.86
Debt / FCF Ratio	-	-29.35	-7.58	-15.63	-4.49	8.38
Quick Ratio	0	0.00	0.00	0.01	0.01	0.23
Current Ratio	0	0.00	0.00	0.01	0.01	0.25
Asset Turnover	0.29	1.21	3.94	3.14	34.20	3.69
Interest Coverage	0	-2.49	-2.14	-4.91	-3.48	-0.76
Return on Equity (ROE)	-	22.42%	33.58%	29.18%	53.12%	31.39%
Return on Assets (ROA)	-	-4858.13%	-8407.15%	-3833.00%	-5604.37%	-118.89%
Return on Capital (ROIC)	-	29.67%	44.97%	58.62%	103.59%	59.96%
Earnings Yield	-884.34%	-116.41%	-155.08%	-64.51%	-361.43%	-36.93%
FCF Yield	-67.13%	-10.74%	-38.27%	-9.14%	-98.90%	10.30%
Buyback Yield / Dilution	-28.38%	-7.34%	-7.85%	-8.86%	-18.33%
Total Shareholder Return	-28.38%	-7.34%	-7.85%	-8.86%	-18.33%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.